ART Cohort Collaboration

Publications and conference presentations

Home
Risk Calculator
Collaborating cohorts
Members of the study groups
Steering Committee
Publications
Supplementary material
Collaborators only

 

Publications

2010

Antiretroviral Cohort Collaboration (ART-CC): Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 cohort studies. CID 2010;50:1387-96. Writing committee: John Gill, Margaret May, Charlotte Lewden, Michael Saag, Michael Mugavero, Peter Reiss, Ross J Harris, Amanda Mocroft, Bruno Ledergerber, Christoph Fux, Amy C Justice, Robert S Hogg, Antonella D'Arminio Monforte, Fiona Lampe, Jordi Casabona, Janne Vehreschild, Pavel Khaykin, Jonathan AC Sterne.

2009

May M, Wood R, Myer L, Taffe P, Rauch A, Battegay M, et al. CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland. J Infect.Dis 2009:200:1729-35.

Antiretroviral Cohort Collaboration (ART-CC): Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. JAIDS 2009;52:357-63. Writing committee: David M. Moore, Ross Harris, Viviane Lima, Bob Hogg, Margaret May, Benita Yip, Amy C Justice, Amanda Mocroft, Peter Reiss, Fiona Lampe, Geneviève Chêne, Dominique Costagliola, Luigia Elzi, Michael J. Mugavero, Antonella D'Arminio Monforte, Caroline Sabin, Daniel Podzamczer, Gerd Fätkenheuer, Schlomo Staszewski, John Gill, Jonathan A C Sterne.

Antiretroviral Cohort Collaboration (ART-CC): Prognosis of patients treated with combined antiretroviral therapy from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. AIDS 2009;23:2199-208. Writing committee: Emilie Lanoy, Margaret May, Amanda Mocroft, Andrew N Phillips, Amy C Justice, Geneviève Chêne, Hansjakob Furrer, Antonella D'Arminio Monforte, Lluis Force, John Gill, Ross J Harris, Robert S Hogg, Mari Kitahata, Jürgen Rockstroh, Michael Saag, Schlomo Staszewski, Frank de Wolf, Tim Sterling, Jonathan AC Sterne, Dominique Costagliola.

Antiretroviral Cohort Collaboration (ART-CC): Timing of initiation of antiretroviral therapy in AIDS-free HIV-1 infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009;18:1352-1363. Writing Committee: Jonathan A C Sterne, Margaret May, Dominique Costagliola, Frank de Wolf, Andrew Phillips, Ross Harris, Michele L Jönsson, Maria Prins, John Gill, Francois Dabis, Jose Maria Miró, Amy Justice, Bruno Ledergerber, Gerd Fätkenheuer, Robert Hogg, Antonella D’Arminio Monforte, Michael Saag, Mari Kitahata, Colette Smith, Matthias Egger, Stephen R. Cole.

Antiretroviral Cohort Collaboration (ART-CC): Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in eight industrialized countries. International Journal of Epidemiology 2009;38:1624-1633. Writing committee: Ross J Harris, Jonathan AC Sterne, Sophie Abgrall, François Dabis, Peter Reiss, Michael Saag, Andrew N Phillips, Geneviève Chêne, John M Gill, Amy C Justice, Jürgen Rockstroh, Caroline A Sabin, Amanda Mocroft, Heiner C Bucher, Robert S Hogg, Antonella D'Arminio Monforte, Margaret May, Matthias Egger.

The ART Cohort Collaboration: Variable impact on mortality of AIDS defining events diagnosed during combination antiretroviral therapy: Not all AIDS Defining Conditions are Created Equal. Clinical Infectious Diseases 2009, Clinical Infectious Diseases 2009;48: 1138-1151. Writing committee: Mocroft, A., Sterne, J., Egger, M., May, M., Grabar, S., Furrer, H., Sabin, C., Fatkenheuer, G., Justice, A., Reiss, P., d’Arminio Monforte, A., Gill, J., Hogg, R., Bonnet, F., Kitahata, M., Staszewski, S., Casabona, J., Harris, R. and Saag, M.

The ART Cohort Collaboration: Prognostic importance of anaemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries. Antiviral Therapy 2009, Antiviral Therapy 2009;13: 959-967. Writing committee: Harris, R.J. Sterne, J.A.C., Abgrall, S., Dabis, F., Reiss, P., Saag, M., Phillips, A.N., Chêne, G., Gill, J.M. Justice, A.C., Rockstroh, J., Sabin, C.A. Mocroft, A. Bucher, H.C. Hogg, R.S. D'Arminio Monforte, A., May, M. and Egger, M. Marcel Zwahlen, Ross Harris, Robert Hogg, Dominique Costagliola, Margaret May, Frank de Wolf, John Gill, Gerd Fätkenheuer, Charlotte Lewden, Mike Saag, Shlomo Staszewski, Antonella d’Arminio Monforte, Jordi Casabona, Fiona Lampe, Amy Justice, Viktor von Wyl, Matthias Egger.

2008

The ART Cohort Collaboration: Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? AIDS 2008; 22: 2481-2492. Writing committee: Michael J. Mugavero, Margaret May, Ross Harris, Michael S. Saag, Dominique Costagliola, Matthias Egger, Andrew Phillips, Huldrych Günthard, Francois Dabis, Robert Hogg, Frank de Wolf, Gerd Fatkenheuer, John Gill, Amy Justice, Antonella D'Arminio Monforte, Fiona Lampe, Jose Maria Miró, Schlomo Staszewski , Mari Kitahata and Jonathan A C Sterne.

The ART Cohort Collaboration: Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293-299. Writing committee: Hogg, R., Lima V., Sterne, J.A.C. Grabar, S., Battegay, M., Bonarek, M., D’Arminio Monforte, A., Esteve, A., Gill, M.J., Harris, R., Justice, A., Hayden, A., Lampe, F., Mocroft, A., Mugavero, M.J., Staszewski, S., Wasmuth J.C., van Sighem, A., Kitahata, .M, Guest, J., Egger, M. and May, M.

2007

The Antiretroviral Therapy in Low-Income Countries Collaboration of the International epidemiological Databases to Evaluate AIDS (IeDEA) and The ART Cohort Collaboration: Tuberculosis after Initiation of Antiretroviral Therapy in Low-Income and High-Income Countries. CID 2007;45:1518–1521

The ART Cohort Collaboration: Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1 Infected Patients. J Acquir Immune Defic Syndr 2007; 46:607–615. Writing committee: Jonathan A C Sterne, Margaret May, Caroline Sabin, Andrew Phillips, Dominique Costagliola, Geneviève Chêne, Amy C Justice, Frank de Wolf, Robert Hogg, Manuel Battegay, Antonella D’Arminio Monforte, Norbert Schmeisser, Schlomo Staszewski, John Gill and Matthias Egger.

May M, Sterne JA, Shipley M, Brunner E, d'Agostino R, Whincup P, Ben-Shlomo Y, Carr A, Ledergerber B, Lundgren JD, Phillips AN, Massaro J, Egger M. A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. Int J Epidemiol, 2007 Dec;36(6):1309-18

Sterne JA, May M, Bucher HC, Ledergerber B, Furrer H, Cavassini M, Bernasconi E, Hirschel B, Egger M; Swiss HIV Cohort. HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy. J Intern Med 2007 261:255-67

The ART Cohort Collaboration: Prognosis of HIV-1 infected patients up to five years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007, 21:1185–1197 Writing committee: Margaret May, Jonathan Sterne, Caroline Sabin, Dominique Costagliola, Amy Justice, Rodolphe Thiébaut, John Gill, Andrew Phillips, Peter Reiss, Robert Hogg, Bruno Ledergerber, Antonella D'Arminio Monforte, Norbert Schmeisser, Schlomo Staszewski and Matthias Egger

2006

The ART Cohort Collaboration. Rates of disease progression according to initial HAART regimen: A collaborative analysis of 12 prospective cohort studies. Journal of Infectious Diseases 2006 194: 612-622 Writing committee: Robert Hogg, Margaret May, Andrew Phillips, Dominique Costagliola, Jonathan Sterne, Caroline Sabin, Frank De Wolf, Bruno Ledergerber, Antonella D'Arminio Monforte, Amy Justice, John Gill, Gregory Fusco, Schlomo Staszewski, Jurgen Rockstroh, Geneviève Chêne and Matthias Egger

The ART Cohort Collaboration: HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet 2006 368: 451–58. Writing committee: Margaret T. May, Jonathan A.C. Sterne, Dominique Costagliola, Caroline A. Sabin, Andrew N. Phillips, Amy C. Justice, Francois Dabis, John Gill, Jens Lundgren, Robert S. Hogg, Frank de Wolf, Gerd Fätkenheuer, Schlomo Staszewski, Antonella d'Arminio Monforte, Matthias Egger

Braitstein P, Brinkhof MWG, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg D, Balestre E, Sterne J, May M, Egger M; Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and the ART Cohort Collaboration. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006 367: 817-824

2005

The ART Cohort Collaboration: Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America. Clinical Infectious Diseases 2005; 41: 1772–82 (pdf of paper here) Writing committee: Enrico Girardi, Caroline A. Sabin, Antonella d’Arminio Monforte, Bob Hogg, Andrew N. Phillips, M. John Gill, Francois Dabis, Peter Reiss, Ole Kirk, Enos Bernasconi, Sophie Grabar, Amy Justice, Schlomo Staszewski, Gerd Fatkenheuer and Jonathan A. C. Sterne

The ART Cohort Collaboration: AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others? AIDS 2005 19: 1995-2000 Writing committee: Sabin, CA, Hogg B, Dabis F, Gill MJ, Phillips AN, Reiss P, Fätkenheuer G, Grabar S, Lundgren J, Justice A, Ledergerber B, d'Arminio Monforte A, Staszewski A and Sterne JAC

Margaret May, Kholoud Porter, Jonathan A. C. Sterne, Patrick Royston, Matthias Egger, ART-CC (The Antiretroviral Therapy Cohort Collaboration) and CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe). Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data. Journal of Clinical Epidemiology 2005 58: 1033-1041

The Antiretroviral Therapy (ART) Cohort Collaboration: AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others? AIDS 2005 19 : 1995-2000. Writing committee: Sabin, CA, Hogg, B, Dabis, F, Gill, MJ, Phillips, AN, Reiss, P, Fätkenheuer, G, Grabar, S, Lundgren, J, Justice, A, Ledergerber, B, d'Arminio Monforte, A, Staszewski, A and Sterne, JAC

Sterne JAC, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, Rickenbach M, Robins JM, Egger M; Swiss HIV Cohort Study. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005 366: 378-84

The ART Cohort Collaboration: The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Archives of Internal Medicine 2005 165: 416-23 Writing committee: D'Arminio MA, Sabin CA, Phillips A, Sterne JAC, May M, Justice AC, Dabis F, Grabar C, Ledergerber B, Gill J, Reiss P and Egger M.

2004

May M, Royston P, Egger M, Justice AC, Sterne JAC and the ART Cohort Collaboration. Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Statistics in Medicine 2004 23: 2375-98

2003

The ART Cohort Collaboration: Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet 2003 362:679-86 Writing committee: Chene G, Sterne JAC, May M, Costagliola D, Ledergerber B, Phillips AN, Dabis F, Lundgren J, D'Arminio Monforte A, de Wolf F, Hogg R, Reiss P, Justice A, Leport C, Staszewski S, Gill J, Fatkenheuer G and Egger M

2002

The ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002 360: 119-29 Writing committee: Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, Costagliola D, D'Arminio Monforte A, de Wolf F, Reiss P, Lundgren JD, Justice AC, Staszewski S, Leport C, Hogg RS, Sabin CA, Gill MJ, Salzberger B and Sterne JAC.

 

Conference Presentations

18th Conference on Retroviruses and Opportunistic Infections, Boston, USA, Feb 2011

Inma Jarrin, Julia del Amo and the ART Cohort Collaboration (ART-CC). Differences in mortality rates among treated patients according to geographical origin and ethnicity/race.

Sophie Abgrall, R Cornish, MMugavero, M Saag, M May, J Sterne and the ART Cohort Collaboration. Outcomes after switch from or interruption to first ART regimen.

16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, Feb 2009

Jonathan Sterne and the ART Cohort Collaboration (ART-CC). When should HIV-1 infected persons initiate antiretroviral therapy? Collaborative analysis of HIV Cohort Studies

John Gill and the ART Cohort Collaboration (ART-CC). Causes of Death in Patients Treated with ART, 1996 to 2006: Collaborative Analysis of 13 Cohort Studies

15th Conference on Retroviruses and Opportunistic Infections, Boston, USA, Feb 2008

Michael Mugavero, Margaret May, Heather Ribaudo, Jonathan Sterne, Sonia Napravnik, Matthias Egger, Michael Saag, Roy Gulick. Outcomes of Abacavir and Efavirenz based HAART: Comparison of ACTG 5095 Trial Results with Observational Cohort Studies

14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, USA, Feb 2007

Matthias Egger. Plenary: Outcomes of ART in Resource-Limited and Industrialized Countries

Amanda Mocroft and the ART Cohort Collaboration (ART-CC). Clinical Endpoints for Randomized Clinical Trials: All AIDS-defining Conditions Are Not Created Equal

Jonathan Sterne and the ART Cohort Collaboration (ART-CC). Prognosis of Patients Treated with cART from 36 Months after Initiation of Therapy, according to Current and Previous CD4 Cell Count

Michael Mugavero and the ART Cohort Collaboration (ART-CC). A Comparison of Commonly Prescribed cART Regimens: Do Differences in Short-term Virologic Success Translate to Better Clinical Outcomes?

Robert Hogg and the ART Cohort Collaboration (ART-CC). Life Expectancy of Persons at the Time of Initiating cART in Hgh-income Countries

13th Conference on Retroviruses and Opportunistic Infections, Denver, USA, Feb 2006

Jonathan Sterne, M May, D Costagliola, M Egger, R Hogg, A D'Arminio Monforte, G Chene, M Gill, F De Wolf, S Cole, and ART Cohort Collaboration. Estimating the Optimum CD4 Threshold for Starting HAART in ART-naïve HIV-infected Individuals

Robert Hogg, J Lundgren, D Costagliola, A Monforte, B Ledergerber, F de Wolf, G Fusco, S Staszewski, G Chêne, A Phillips, J Gill, J Rockstroh, M May, J Sterne, M Egger, and ART Cohort Collaboration. Mortality Rates According to Initial HAART Regimen: A Collaborative Analysis of 12 Prospective Cohort Studies

Caroline Sabin, Antonella D'Arminio Monforte, Margaret May, Sophie Grabar, Peter Reiss, Jens Lundgren, Amy Justice, Schlomo Staszewski, Catherine Leport, Francois Dabis, Julio S.G. Montaner, Margaret Johnson, M John Gill, Gerd Fatkenheuer, Matthias Egger and the ART Cohort Collaboration. The Changing Incidence of Clinical AIDS Events in 12,574 Treatment-naive Patients Starting HAART

12th Conference on Retroviruses and Opportunistic Infections, Boston, USA, Feb 2005

Robert Hogg, J Lundgren, D Costagliola, A Monforte, B Ledergerber, F De Wolf, G Fusco, S Staszewski, G Chêne, A Phillips, J Gill, J Rockstroh, M May, J Sterne, M Egger and ART-CC. Mortality rates according to initial HAART regimen: a collaborative analysis of 12 prospective cohort studies.

Francois Dabis, M Schechter, M Egger, and ART-LINC/ART-CC Study Groups. Response to Highly Active Antiretroviral Therapy in low- and high-income countries: Analysis of clinical databases from 4 continents.

AIDS 2004, Bangkok, July 2004

Margaret May and Jonathan Sterne for ART-CC. Changes in the effect of prognostic factors with time on HAART: ART Cohort Collaboration.

10th Conference on Retroviruses and Opportunistic Infections Boston, USA, Feb 2003

J. A. C. Sterne, M. May, D. Costagliola, P. Pezzotti, B. Ledergerber, F. de Wolf, J. Lundgren, J. S. Fusco, S. Staszewski, F. Raffi, R. S. Hogg, A. N. Phillips, M. J. Gill, G. Fatkenheuer, G. Chêne and ART-CC. Does it matter where you came from? Prognosis of patients starting potent therapy, according to initial response.

AIDS 2002, Barcelona, July 2002

M May, J A C Sterne, D Costagliola, P Pezzotti, B Ledergerber, F de Wolf , J D Lundgren, A C Justice, V Miller, G Chêne, F Dabis, R S Hogg, C Sabin, M J Gill, B Salzberger, M Egger. Construction and validation of a prognostic model for progression to AIDS or death in drug-naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration.

G Chêne, M May, D Costagliola, A d'Arminio Monforte, C Junghans, F de Wolf, J D Lundgren, G Fusco, V Miller, C Leport, F Dabis, R S Hogg, A N Phillips, M J Gill, B Salzberger, J A C Sterne, M Egger. Prognosis of HIV-1 infected drug naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration.

 

Last updated

5th April 2011